China Biotech Services Holdings Ltd. announced changes to its US$6 million outstanding convertible bonds. The company has added new guarantees to strengthen investor security, including commitments from a major shareholder and the chairman. As of now, none of the bonds have been converted to shares, and the bonds are due for repayment in December 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.